Categories: ImplantsNews

Tenon Medical, Inc. Announces Timing of Second Quarter 2024 Financial Results

LOS GATOS, CA / ACCESSWIRE / July 30, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) (“Tenon” or the “Company”), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced plans to release financial results for the second quarter 2024 ended June 30, 2024 after market close on Tuesday, August 13, 2024. The Company will also hold a conference call the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.

Date:

Tuesday, August 13, 2024

Time:

4:30 p.m. Eastern time

Dial-in:

1-877-407-0792

International Dial-in:

1-201-689-8263

Webcast:

TNON Conference Call

Please dial in at least 10 minutes before the start of the call to ensure timely participation.

An audio playback of the call will be available through August 27, 2024, on Tenon’s Investor Relations website at http://ir.tenonmed.com/ or via telephone replay by dialing 1-844-512-2921 (USA) or 1-412-317-6671 (International). The access code will be 13747648.

About Tenon Medical, Inc.

Tenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran® SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran® Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Since the national launch of the Catamaran® SI Joint Fusion System in October 2022, Tenon is focused on three commercial opportunities with its System in the SI Joint market which includes: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants and 3) SI Joint fusion adjunct to a spine fusion construct. For more information, please visit https://www.tenonmed.com/.

The Tenon Medical logo, Tenon Medical and Catamaran are registered trademarks of Tenon Medical, Inc.

Investor Contact

Shannon Devine
MZ North America
203-741-8811
tenon@mzgroup.us

SOURCE: Tenon Medical, Inc.

View the original press release on accesswire.com

Staff

Recent Posts

Dr. Devgan Scientific Beauty Launches Surgical Instruments Line to Address Gender Inequities in Surgery

Dr. Devgan Scientific Beauty introduces ergonomic surgical tools designed by renowned New York City plastic…

29 mins ago

New Funding Announced for Revolutionary Disease Detection Technology

Noze is the first-ever Canadian company to receive investment funding from the Bill & Melinda…

29 mins ago

Manifest and SolaSec Form Strategic Partnership

WESTPORT, Conn., July 30, 2024 /PRNewswire/ -- Manifest, a leader in SBOM and AIBOM management,…

29 mins ago

Stonebrook Announces Long-Term Partnership with Leading TPA and Healthcare Network for Innovative Services

ENCINO, Calif., July 30, 2024 /PRNewswire/ -- Stonebrook is thrilled to announce the launch of…

29 mins ago

Doctors Group Improves Employee Retention Rates with Empathy Training

Empathetics unveils new white paper BOSTON, July 30, 2024 /PRNewswire/ -- Empathetics, Inc. the pioneer…

29 mins ago

2024 Hooley Award Winners Announced and Celebrated at ImageTrend Connect

LAKEVILLE, Minn., July 30, 2024 /PRNewswire/ -- ImageTrend, LLC announced the winners of its 2024…

29 mins ago